Abstract ISG15 overexpression in cancers has emerged as a diagnostic marker and therapeutic target. This study identifies ISGylation, a post-translational modification mediated by ISG15, as a critical driver of CRC progression through metabolic reprogramming and oncogenic signaling. Clinical and multi-omics analyses reveal elevated ISG15 and ISGylation levels in CRC tissues, correlating with advanced clinicopathological features and poor prognosis.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Junwei
Contact Junwei, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack